Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Status
Terminated
Classification
Class II
Report Date
April 17, 2013
Termination Date
January 15, 2014
Product Information
Product description
Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.
Product quantity
62,187 bottles
Reason for recall
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide
Location & Firm
Recalling firm
Teva Pharmaceuticals USA, Inc.
Address
650 Cathill Rd
United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—
Codes & Dates
Recall number
D-247-2013
Event ID
64480
Recall initiation date
February 26, 2013
Center classification date
April 10, 2013
Code info
a) Lot #: 30304253A, Exp 12/13; b) Lot #: 30304144A, Exp 12/13 and 30304477A, Exp 03/14